HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alberto-Culver

This article was originally published in The Rose Sheet

Executive Summary

Acquires La Farmaco (Buenos Aires, Argentina), which holds market leader positions for its Veritas deodorant body powder and glycerin soaps as well as an eponymous glycerin soap, as a way to open up the firm's established lines of distribution in South America to Alberto VO5, St. Ives Swiss Formula and other brands. Alberto announced and completed the deal Jan. 7. Annual sales for the 94-year-old La Farmaco, which manufacturers between 30 and 40 personal care products, total approximately $15 mil. Following completion of the acquisition, Alberto will expand the Argentina manufacturing facilities and will produce its brands at the site. The Alberto brands currently are manufactured in Mexico City and have limited distribution in South America. Terms of the purchase were not disclosed

You may also be interested in...



OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Chart: Weekly Trademark Review -- Nov. 2, 2010

Weekly Trademark Review

UsernamePublicRestriction

Register

RS006169

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel